Cargando…
Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein
Rabies virus (RABV) causes fatal encephalitis in more than 59,000 people yearly. Upon the bite of an infected animal, the development of clinical disease can be prevented with post-exposure prophylaxis (PEP), which includes the administration of Rabies immunoglobulin (RIG). However, the high cost an...
Autores principales: | Hellert, Jan, Buchrieser, Julian, Larrous, Florence, Minola, Andrea, de Melo, Guilherme Dias, Soriaga, Leah, England, Patrick, Haouz, Ahmed, Telenti, Amalio, Schwartz, Olivier, Corti, Davide, Bourhy, Hervé, Rey, Félix A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992781/ https://www.ncbi.nlm.nih.gov/pubmed/32001700 http://dx.doi.org/10.1038/s41467-020-14398-7 |
Ejemplares similares
-
Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022) -
The shift in rabies epidemiology in France: time to adjust rabies post-exposure risk assessment
por: Parize, Perrine, et al.
Publicado: (2018) -
A combination of two human monoclonal antibodies cures symptomatic rabies
por: de Melo, Guilherme Dias, et al.
Publicado: (2020) -
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
por: De Benedictis, Paola, et al.
Publicado: (2016) -
Advances in Genomics for Drug Development
por: Spreafico, Roberto, et al.
Publicado: (2020)